drugset / Trial / NCT06502158

Mifepristone vs Misoprostol

NCT06502158

Phase 1 Recruiting 94 enrolled Montefiore Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The Investigator team hypothesizes that in a randomized trial comparing mifepristone-alone or misoprostol-alone for cervical preparation for procedural abortions at 12 to 16 weeks in hospital-based care, the proportion of patients who achieve successful cervical dilation will be different between the study groups.

Timeline

Start
2024-10-31
Primary completion
2026-10
Completion
2026-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 200 mg
Subject Misoprostol Other / unclassified 600 ug

Indications

No indication recorded.